Clinical Trial Update: A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A pilot study investigating the efficacy and safety of dupilumab versus placebo in patients with Netherton syndrome (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Netherton Syndrome

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Netherton Syndrome | Phase 2, Phase 3 | Status: UNKNOWN